A prospective study of four-week esomeprazole treatment for ulcer healing after gastric endoscopic submucosal dissectio
Not Applicable
Recruiting
- Conditions
- early gastric cancer, gastric adenoma
- Registration Number
- JPRN-UMIN000009180
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
age below 20, severe complication such as severe nausea after ESD, severe mental disease such as severe schizophrenia, hypersensitivity to PPI, severe hyperthyloidism, severe heart disease, severe renal dysfunction, severe liver dysfunction, expectant mothers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the healing rates of post-ESD ulcers in response to the 4-week esomeprazole (20mg/day) treatment
- Secondary Outcome Measures
Name Time Method